<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>Disc on Tenu Tech Brief</title>
    <link>https://cluster-site.onrender.com/tags/disc/</link>
    <description>Recent content in Disc on Tenu Tech Brief</description>
    <generator>Hugo -- 0.146.0</generator>
    <language>en-us</language>
    <lastBuildDate>Tue, 24 Feb 2026 06:03:26 +0000</lastBuildDate>
    <atom:link href="https://cluster-site.onrender.com/tags/disc/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Disc Medicine Rare Disease Drug Picked for Faster Regulatory Review Is Rejected by the FDA</title>
      <link>https://cluster-site.onrender.com/posts/disc-medicine-rare-disease-drug-picked-for-faster-regulatory-review-is-rejected-by-the-fda/</link>
      <pubDate>Mon, 16 Feb 2026 15:22:04 +0000</pubDate>
      <guid>https://cluster-site.onrender.com/posts/disc-medicine-rare-disease-drug-picked-for-faster-regulatory-review-is-rejected-by-the-fda/</guid>
      <description>• The FDA asked for more data to determine whether Disc Medicine&amp;rsquo;s bitopertin is benefiting patients with erythropoietic protoporphyria, a rare blood disorder. • Analysts say it&amp;rsquo;s</description>
    </item>
  </channel>
</rss>
